Document Detail

Why hydroxyethyl starch solutions should NOT be banned from the operating room.
MedLine Citation:
PMID:  25432553     Owner:  NLM     Status:  In-Data-Review    
This review summarises the new insights into the physiology of perioperative fluid therapy and analyses recent studies of the safety of the use of HES solutions in the fluid management of critically ill patients. This analysis reveals a number of methodological issues in the three major studies that have initiated the recommendation of the European Medicine Agency to ban hydroxyethyl starches from clinical practice. It is concluded that, when used in the proper indication, and taking into account the recommended doses, hydroxyethyl starches continue to have a place in perioperative fluid management.
Stefan De Hert; Luc De Baerdemaeker
Related Documents :
22557193 - Antimicrobial properties of roots of medicinal plants.
21321653 - Fluid management in major burn injuries.
22523883 - Uterine fibroid managed by uterine artery embolization and delivered vaginally by obste...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anaesthesiology intensive therapy     Volume:  46     ISSN:  1731-2515     ISO Abbreviation:  Anaesthesiol Intensive Ther     Publication Date:    2014 Nov-Dec
Date Detail:
Created Date:  2014-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101472620     Medline TA:  Anaesthesiol Intensive Ther     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  336-41     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ten good reasons to practice ultrasound in critical care.
Next Document:  Why crystalloids will do the job in the operating room.